Lupin Current Share Price | Lupin Stock Screener
LUPIN
Pharmaceuticals
Lupin Current Stock Price Today
Live Share Price NSE
₹2083.00
▼
-15.10 (-0.72%)
Live Share Price BSE
₹2144.70
▲
52.70 (2.52%)
As of September 18, 2026, the live Lupin share price (NSE: LUPIN) is ₹2,083.00 on NSE and ₹2,144.70 on BSE, down 0.72% from the previous close, with shares trading between ₹2,075.00 and ₹2,114.70 in today's trading session, and a 52-week range of ₹1,915.00–₹2,514.80.
Browse LUPIN balance sheet details to support your investment research.
Use the Lupin stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Lupin Market Cap
₹93,504.05 Cr.
LUPIN P/E Ratio (TTM)
16.93
Lupin P/B Ratio
4.19
EPS (TTM)
₹116.75
Dividend Yield
0.88%
Debt to Equity
0.30
LUPIN 52 Week High
₹2514.80
Lupin 52 Week Low
₹1915.00
Operating Margin
29.00%
Profit Margin
16.97%
LUPIN Revenue (TTM)
₹8,348.00
EBITDA
₹2,520.00
Net Income
₹1,417.00
Total Assets
₹38,365.00
Total Equity
₹22,513.00
Lupin Current Share Price Chart
Track the current Lupin share price and stock price with an interactive chart. Analyse LUPIN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Lupin stock quote in one place.
Lupin Company Profile - Fundamental Screener
Screen Lupin company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for LUPIN shares.
Lupin is a global pharmaceutical company producing branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. Founded in 1983, it operates in over 100 markets, specializing in cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal, anti-infective, and NSAID therapies. Lupin is a leader in anti-TB and cephalosporins segments. The...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
M D Gupta
ISIN
INE326A01037
Website
https://www.lupin.com/
Lupin Balance Sheet Screener
Screen LUPIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 38,365 | 29,205 | 23,997 | 22,956 | 21,821 | 23,610 | 24,984 | 27,949 | 26,305 | 26,607 |
| Current Assets | 24,027 | 16,799 | 13,448 | 12,451 | 12,458 | 13,986 | 15,413 | 13,854 | 12,210 | 11,953 |
| Fixed Assets | 10,994 | 9,719 | 8,878 | 8,355 | 7,382 | 7,881 | 7,938 | 11,087 | 10,362 | 11,033 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3,200 | 2,949 | 1,122 | 1,148 | 1,101 | 1,316 | 3,178 | 8,030 | 7,593 | 6,955 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 22,513 | 17,294 | 14,374 | 12,543 | 12,222 | 13,858 | 12,581 | 13,789 | 13,617 | 13,532 |
| Share Capital | 91 | 91 | 91 | 91 | 91 | 91 | 91 | 91 | 90 | 90 |
| Reserves & Surplus | 22,357 | 17,112 | 14,199 | 12,374 | 12,062 | 13,712 | 12,446 | 13,652 | 13,487 | 13,407 |
Lupin Income Statement Screener - Profit & Revenue Analysis
Screen Lupin income statement and profit fundamentals.
Analyze LUPIN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lupin share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,348 | 7,533 | 7,215 | 6,921 | 6,243 | 5,619 | 5,672 | 5,539 | 5,582 | 4,924 | 5,109 | 4,980 | 4,765 | 4,368 | 4,263 |
| Expenses | 5,827 | 5,120 | 5,332 | 4,706 | 4,541 | 4,346 | 4,412 | 4,332 | 4,359 | 3,964 | 4,160 | 4,121 | 3,958 | 3,852 | 3,790 |
| EBITDA | 2,520 | 2,412 | 1,883 | 2,215 | 1,702 | 1,273 | 1,261 | 1,207 | 1,223 | 960 | 950 | 859 | 807 | 515 | 473 |
| Operating Profit % | 29.00% | 31.00% | 25.00% | 31.00% | 26.00% | 22.00% | 21.00% | 21.00% | 21.00% | 19.00% | 18.00% | 17.00% | 17.00% | 11.00% | 11.00% |
| Depreciation | 453 | 447 | 313 | 317 | 299 | 393 | 272 | 257 | 248 | 457 | 257 | 248 | 235 | 264 | 220 |
| Interest | 110 | 120 | 115 | 108 | 92 | 89 | 67 | 71 | 68 | 71 | 74 | 81 | 86 | 93 | 84 |
| Profit Before Tax | 2,017 | 1,928 | 1,522 | 2,007 | 1,416 | 896 | 1,071 | 1,055 | 993 | 498 | 736 | 630 | 559 | 259 | 246 |
| Tax | 600 | 459 | 342 | 522 | 194 | 114 | 212 | 195 | 188 | 130 | 117 | 134 | 106 | 16 | 89 |
| Net Profit | 1,417 | 1,469 | 1,181 | 1,485 | 1,222 | 782 | 859 | 860 | 806 | 368 | 619 | 495 | 453 | 242 | 158 |
| EPS | 30.95 | 34.83 | 25.74 | 32.36 | 26.70 | 16.93 | 18.75 | 18.70 | 17.58 | 7.89 | 13.47 | 10.76 | 9.94 | 5.19 | 3.38 |
Lupin Cash Flow Screener - Liquidity Fundamentals
Screen LUPIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 7,335 | 3,000 | 3,648 | 1,897 | 367 | 1,822 | 1,469 | 1,666 | 1,751 | 4,114 |
| Investing Activities | -3,865 | -4,172 | -1,712 | -1,287 | 1,292 | -1,240 | 1,107 | -3,283 | 470 | -2,527 |
| Financing Activities | -846 | 1,732 | -2,184 | -337 | -1,572 | -1,885 | -891 | 744 | -1,492 | 433 |
| Net Cash Flow | 2,624 | 560 | -248 | 273 | 87 | -1,303 | 1,685 | -872 | 729 | 2,019 |
Lupin Shareholding Pattern Screener
See Lupin shareholding pattern with promoter, FII, and DII holdings.
Check Lupin promoter holding and ownership changes for LUPIN on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.86% | 46.85% | 46.92% | 46.90% | 46.90% | 46.89% | 47.01% | 46.98% |
| FII Holding | 21.71% | 22.42% | 21.46% | 21.25% | 20.49% | 21.49% | 18.28% | 19.32% |
| DII Holding | 25.32% | 24.65% | 25.41% | 25.56% | 26.55% | 25.58% | 27.76% | 26.78% |
| Govt Holding | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 5.05% | 5.06% | 5.10% | 5.23% | 5.12% | 5.10% | 5.70% | 5.65% |
| Other Holding | 1.06% | 1.02% | 1.10% | 1.05% | 0.94% | 0.93% | 1.23% | 1.26% |
| Shareholder Count | 290,411 | 300,283 | 283,210 | 286,604 | 280,256 | 288,931 | 280,248 | 288,537 |
Lupin Share Dividend Screener - Share Yield Analysis
Check Lupin dividend history with payout and yield data.
View Lupin dividend details including ex-dates and amounts for LUPIN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹18.00 | 0.87% |
| 2025-March | ₹12.00 | 0.52% |
| 2024-March | ₹8.00 | 0.39% |
| 2023-March | ₹4.00 | 0.25% |
| 2022-March | ₹4.00 | 0.61% |
| 2021-March | ₹6.50 | 0.87% |
| 2020-March | ₹6.00 | 0.59% |
| 2019-March | ₹5.00 | 0.85% |
| 2018-March | ₹5.00 | 0.68% |
| 2017-March | ₹7.50 | 1.02% |
Lupin Stock Index Membership
See which indices include Lupin stock.
Check LUPIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE100
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX BSEMOI
BSE INDEX DOL100
BSE INDEX ESG100
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MIDSEL
BSE INDEX MSL400
BSE INDEX SNXT50
NIFTY 200
NIFTY 500
NIFTY ALPHA 50
NIFTY ALPHALOWVOL
NIFTY HEALTHCARE
NIFTY INDIA MFG
NIFTY LARGEMID250
NIFTY LOW VOLATILITY 50
NIFTY MID LIQ 15
NIFTY MIDCAP 100
NIFTY MIDCAP 150
NIFTY MIDCAP 50
NIFTY MIDCAP SELECT (MIDCPNIFTY)
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SHARIAH 25
NIFTY TOTAL MKT
NIFTY200 ALPHA 30
NIFTY200MOMENTM30
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MOMENTUM 50
NIFTY500 MULTICAP
NIFTY500 SHARIAH
NIFTYM150MOMNTM50
Lupin Market Events Screener - Corporate Actions
Get Lupin corporate actions including splits, bonuses, and buybacks.
Check Lupin stock events that may affect LUPIN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | -5.12% |
| 2026-08-04 | 2026-08-04 | Annual General Meeting | NA | -4.59% |
| 2026-07-17 | 2026-07-17 | Dividend | ₹ 18.00 /share | 2.34% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 5.68% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 2.72% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 2.76% |
| 2025-08-11 | 2025-08-11 | Annual General Meeting | NA | 1.23% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -2.52% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 12.00 /share | -5.80% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | -2.12% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 1.65% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 0.66% |
| 2024-08-02 | 2024-08-02 | Annual General Meeting | NA | 9.82% |
| 2024-07-16 | 2024-07-16 | Dividend | ₹ 8.00 /share | 10.68% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 4.00 /share | 27.11% |
Lupin Competitors Screener - Peer Comparison
Screen LUPIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 444,717 | 36.34 | 61,674 | 12.69% | 11,565 | 38.94 |
| Divis Laboratories | 243,116 | 83.41 | 11,067 | 13.95% | 2,568 | 57.81 |
| Torrent Pharmaceuticals | 183,052 | 85.57 | 13,886 | 20.34% | 2,138 | 42.03 |
| Zydus Life Science | 111,440 | 23.87 | 27,658 | 17.64% | 5,026 | 43.86 |
| Cipla | 109,705 | 32.76 | 29,045 | 2.24% | 3,870 | 35.04 |
| Laurus Labs | 102,870 | 95.29 | 6,868 | 22.01% | 890 | 56.63 |
| Dr Reddys Laboratories | 95,152 | 30.15 | 35,059 | 3.90% | 4,158 | 39.81 |
| Aurobindo Pharma | 94,535 | 25.82 | 34,145 | 5.56% | 3,503 | 49.75 |
| Lupin | 93,504 | 16.93 | 29,039 | 26.75% | 5,356 | 22.87 |
| Mankind Pharma | 92,759 | 45.72 | 14,636 | 14.85% | 1,938 | 34.16 |
Lupin Company Announcements - News Screener
Screen LUPIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-28 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- ESG Rating | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-08-24 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating | - |
| 2026-08-20 | Exclusive License Agreement With Visus Therapeutics Inc. U.S.A. | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Demise | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-06 | Board Meeting Outcome For Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-08-06 | Board Meeting Outcome for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-08-04 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-04 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |